Skip to content

Trunk and Upper Extremities Program Effect in Decreasing Compensation Patterns in Unilateral Cerebral Palsy Children

Trunk and Upper Extremities Program Effect in Decreasing Compensation Patterns in Unilateral Cerebral Palsy Children: Randomized Control Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06069765
Acronym
TUPEX
Enrollment
40
Registered
2023-10-06
Start date
2025-09-30
Completion date
2027-07-31
Last updated
2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy Infantile, Chronic Pain, Upper Extremity Dysfunction

Keywords

compensation patterns, unilateral cerebral palsy

Brief summary

The goal of this clinical trial is to test the effectiveness of a trunk and upper extremities exercise program. The main questions it aims to answer are: Whether the program decreases compensation patterns in unilateral cerebral palsy children Whether the program decreases pain in unilateral cerebral palsy children Whether the program improves bimanual ability in unilateral cerebral palsy children Participants will undertake and 8-week program exercise at home If there is a comparison group: Researchers will compare with the control group to see if this program decreases compensation patterns.

Detailed description

Children in control group will continue with their daily activities. Children in experimental group, apart from their daily activities, will undertake an 8-week program exercise at home for strengthening the trunk and the proximal part of both upper extremities. It contains 3 progressions that can be applied if needed.

Interventions

OTHERTUPEX

This program contains exercises with their own body weight or with Thera-bands for gaining strength in their shoulder and trunk muscles. It contains some progression exercise if needed. Each session can last between 20 and 30 minutes. Children have to do each session three times a week during 8 weeks.

Sponsors

Universitat Internacional de Catalunya
CollaboratorOTHER
Fundacio Aspace Catalunya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

One member of the research team responsible for carrying out the evaluations of the dependent variables and the collection of data carried out by the participant himself and/or his families, will remain blinded to the assignment of the participants to the study groups. In this sense, it is worth saying that the person responsible for carrying out the evaluations will do so only for the main variable, that is to say, he will be the one who will carry out the registration of the compensatory movements of the proximal part of the upper limb and trunk through the DLC . The secondary response variables are evaluated through self-administered scales and this same evaluator will be in charge of collecting the data provided by the families.

Eligibility

Sex/Gender
ALL
Age
8 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Unilateral cerebral palsy diagnostic * Level I or II of the Manual Ability Scale Classification

Exclusion criteria

* Have received any intervention with botulinum toxin or shock waves in the previous six months or have them scheduled during the intervention * Are undergoing treatment with intensive therapies. * To have known alteration in the hips * Have very serious attention or comprehension difficulties that prevent them from following instructions. * Suffer uncontrolled epilepsies * Suffer from severe visual problems.

Design outcomes

Primary

MeasureTime frameDescription
Rate of variance of the Compensation patterns8 weeksDeepLabCut (DLC) (Artificial Intelligence). Calculate the kinematic difference of the body marks during the activities

Secondary

MeasureTime frameDescription
Intensity of pain8 weeksFace Pain Scale - Revised (FPS-R). The face marked is compared before and after the treatment. 0 is the minimum scores, meaning no pain, and 10 is the maximum score, meaning really severe pain.
Location of pain8 weeksIn the Body Diagram. The location of the pain is compared before and after the treatment
Bimanual ability8 weeksChildren Hand-Use Experience Questionaire 2.0 (CHEQ 2.0). Whether they are more capable of doing more bimanual activities or not. The maximum score in each question is 100 and the minimum is 0. 100 means children use their hands like the neurotypical children, and 0 means they can't use the affected hand at all.

Contacts

Primary ContactGeorgina Domenech Garcia
gdomenech@uic.es+34 656707865
Backup ContactCaritat Bagur Calafat
cbagur@uic.es+34 656584779

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026